Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Align Technology (ALGN) · oqro.io/stocks/ALGN · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Have Align Technology insiders bought shares recently?
No open-market purchase by an insider of Align Technology was filed in the last 90 days. The latest on record was on Aug 1, 2025.
How often do Align Technology insiders buy and sell shares?
Since 2000, Align Technology insiders reported 59 open-market purchases and 1,426 sales on Forms 4 and 5, with purchases in 8 different years, most recently 2025.
Who is selling Align Technology stock?
No open-market sale by an insider of Align Technology (ALGN) was filed with the SEC in the last 90 days.
Do members of Congress trade ALGN?
No trade in Align Technology (ALGN) was disclosed by a member of Congress in the last 12 months.
When does Align Technology report its next results?
Align Technology's next results are expected on Feb 3, 2027, after the market closes. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+16.8% (+$22.36) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $132.81 on Nov 20, 2025 to $155.17 on Nov 20, 2026 (+16.8%). Disclosed in this range: 0 insider trades, 1 pre-arranged insider sale, 0 Congress trades, and 49 13F position changes for 4 quarters ending in it.
$120$140$180$200$220$155.17
DecJan 2026FebMarAprMayJunJulAugSepOctNov
13F holdings, by quarter end
Insider and Congress marks sit on the trade date stated in the filing; solid is a purchase, hollow a sale. A number means several trades too close to tell apart at this range: pick a shorter range or open it for the list. Fund 13F reports are quarter-end snapshots filed up to 45 days later, so they are shown under the chart across the quarter they describe, not on the price line. Congress amounts are official ranges; mark size uses the lower bound. Past moves are not a forecast.Show the 1 trade in this range as a list
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Supplies company based in Tempe, Arizona.
Last 12 months
+16.8%
S&P 500 +5.7% over the same dates
Market value
$10.9B
Close of Nov 20, 2026 × shares outstanding (per ADS where it applies)
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 4.11M shares sold short (5.8% of shares outstanding), −0.9% vs the previous count, 4.0 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
2 tracked managers disclosed the same change for Q3 2026. From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Since Nov 19, 2025, ALGN is up 16.1% and the index fund is up 4.1%: 12 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much ALGN moves
A usual day
±1.5%Half of the sessions moved less than this, half moved more.
Daily range (ATR 14)
3.7%How far the price usually travels in a session, the gap from the day before included. Wilder's 14-session average.
Largest one-day fall
−6.9%Feb 12, 2026
Largest one-day rise
+8.9%Feb 5, 2026
Deepest fall of the year
−29.2%From the close of Feb 11, 2026 to Oct 7, 2026.
Days of 5% or more
12Out of 252 sessions, in either direction.
Beta 1.3(1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
2 tracked managers disclosed the same change for Q3 2026. From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
4 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
31 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Latest results: quarter ending Sep 30, 2026
Revenue
$1.01B
+1.9% vs the same quarter a year earlier
Free cash flow, last 12 months
$603M
This quarter $138M, a year earlier $169M
Net debt
—
Debt —, cash $1.14B, at Sep 30, 2026
Net income, last 12 months
$492M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 28, 2026.
Insiders of Align Technology reported 59 open-market purchases and 1,426 sales since 2000; purchases in 8 different years, most recently 2025.
Year
Bought
Sold
2026
—
$1.51M1×1 trade
2025
$996K1×1 trade
—
2024
$1.53M1×1 trade
$8.19M7×7 trades
2023
$5.2M5×5 trades
—
2022
$4.75M7×7 trades
—
2021
—
$150M76×76 trades
2020
—
$126M71×71 trades
2019
$1.3M3×3 trades
$61.1M49×49 trades
2018
$1.46M2×2 trades
$91.2M36×36 trades
2017
—
$45.2M24×24 trades
2016
—
$33.5M29×29 trades
2015
—
$26.9M27×27 trades
2014
—
$27.3M25×25 trades
2013
—
$298M31×31 trades
2012
—
$66.7M61×61 trades
2011
—
$18.9M32×32 trades
2010
—
$187M51×51 trades
2009
—
$2.13M121×121 trades
2008
$6.54M38×38 trades
$1.58M36×36 trades
2007
—
$24M693×693 trades
2006
$819K2×2 trades
$625M55×55 trades
2000
—
$1.28M1×1 trade
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
When insiders usually buy
Last results
Oct 28, 2026
Within the 30 days after it, until Nov 27, 2026
Next results, expected
Feb 3, 2027
after the market closes; the date can move until the company confirms it
Purchases after results
95%
18 of 19 insider purchases since 2013 came within 30 days after a results announcement
From Align Technology's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know Align Technology's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
Red flags in its filings
Oct 28
Top officer leaving
“Hogan will continue to serve as the Company’s President and CEO through December 31, 2026, at which time he will retire and begin serving as a strategic advisor to the Company under the terms of an Executive Consulting Agreement, executed October 27, 2026 (the “ Hogan Consulting Agreement ”).”
From the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
On the public record for Align Technology over the 12 months to Nov 22, 2026: 2 FDA records.
Federal rules, proposed rules and notices that name the company by its legal name, from the Federal Register. Being named is not the same as being the target of a rule.
Last 30 days
Written by software from the filings listed below · Nov 21, 2026
Funds and stakes. Fund 13F filings recorded in the 30 days show 2 new or larger positions and 0 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter. Capital World Investors now owns 5.3% of ALGN as a passive investor (filed Nov 13, 2026). (Align Technology on OQRO)
Contracts, lobbying and filings. FINRA short interest for ALGN on the settlement date of Oct 30, 2026 was 4,109,362 shares (-0.92% on the previous report), about 3.95 days of average volume. In 13F filings for the quarter ended Sep 30, 2026, the largest positions that grew: Bridgewater Associates (increased, 26,757 shares); ARK Investment Management (increased, 203 shares); the largest that shrank: none on record. A 13F is a quarter-end snapshot with no trade date.
Company reports, price and press. Align Technology filed a Form 8-K on Nov 18, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member. The company's own opening sentence of that report reads: "On November 17, 2026, the Board of Directors (the 'Board') of Align Technology, Inc. (the 'Company') appointed Paul Clancy, 65, to the Board, effective immediately, and Ian Bell, 56, to the Board, effective December 10, 2026."
Things to keep in mind. These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why. A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade. Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
Facts used for this text
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Funds and stakes
Fund 13F filings recorded in the 30 days show 2 new or larger positions and 0 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Capital World Investors now owns 5.3% of ALGN as a passive investor (filed Nov 13, 2026).
Contracts, lobbying and filings
FINRA short interest for ALGN on the settlement date of Oct 30, 2026 was 4,109,362 shares (-0.92% on the previous report), about 3.95 days of average volume.
In 13F filings for the quarter ended Sep 30, 2026, the largest positions that grew: Bridgewater Associates (increased, 26,757 shares); ARK Investment Management (increased, 203 shares); the largest that shrank: none on record. A 13F is a quarter-end snapshot with no trade date.
For fiscal 2025, the company's proxy statement reported total compensation of $19.2M for its principal executive officer, and an average of $4.32M for the other named executive officers.
Company reports, price and press
Align Technology filed a Form 8-K on Nov 18, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member.
The company's own opening sentence of that report reads: "On November 17, 2026, the Board of Directors (the 'Board') of Align Technology, Inc. (the 'Company') appointed Paul Clancy, 65, to the Board, effective immediately, and Ian Bell, 56, to the Board, effective December 10, 2026."
Its announcing sentence reads: "Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that..."
Align Technology filed a Form 8-K on Nov 6, 2026 (Items 1.01, 2.03) that OQRO classes as: signed an important agreement, and took on new debt or obligations.
Its announcing sentence reads: "Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that..."
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
OQRO Intelligence
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Insiders. In the 12 months to Nov 19, 2026, insiders of Align Technology filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 1 open-market sale (about $1.51M, in 1 filing, by 1 person). One Form 4 can list many transactions. In the 12 months before that, they filed 1 open-market purchase (about $996K, in 1 filing) and 0 open-market sales (about $0, in 0 filings). (Align Technology on OQRO)
Congress. Members of Congress filed 0 disclosures on Align Technology in the 12 months to Nov 19, 2026: 0 purchases and 0 sales, by 0 members. In the 12 months before that: 5 disclosures.
Funds and stakes. Fund 13F filings recorded in the 12 months show 23 new or larger positions and 28 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter. Capital World Investors now owns 5.3% of ALGN as a passive investor (filed Nov 13, 2026).
Contracts, lobbying and filings. The Federal Register published a notice, "Certain Clear Aligners and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Granting In Part ", on Jun 8, 2026, naming the company. The Federal Register published a notice, "Certain Clear Aligners and Components Thereof; Institution of Investigation", on Dec 29, 2025, naming the company.
Company reports, price and press. Align Technology filed a Form 8-K on Nov 18, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member. The company's own opening sentence of that report reads: "On November 17, 2026, the Board of Directors (the 'Board') of Align Technology, Inc. (the 'Company') appointed Paul Clancy, 65, to the Board, effective immediately, and Ian Bell, 56, to the Board, effective December 10, 2026."
Who holds it. 670 funds reported a stake in Align Technology in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (6.1% of the value reported), VANGUARD CAPITAL MANAGEMENT LLC (6.0% of the value reported), FMR LLC (5.6% of the value reported).
Attention. The English Wikipedia article on Align Technology was read about 74 times a day in the 7 days to Nov 18, 2026, against a usual 83 a day over the 90 days before. Reads measure attention, not buying or selling.
Things to keep in mind. These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why. A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade. Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
Facts used for this text
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
In the 12 months to Nov 19, 2026, insiders of Align Technology filed 0 open-market purchases (about $0, in 0 filings, by 0 people) and 1 open-market sale (about $1.51M, in 1 filing, by 1 person). One Form 4 can list many transactions.
In the 12 months before that, they filed 1 open-market purchase (about $996K, in 1 filing) and 0 open-market sales (about $0, in 0 filings).
The largest sale: John Morici, EVP, CHIEF FINANCIAL OFFICER, about $1.51M, filed Feb 21, 2026.
Congress
Members of Congress filed 0 disclosures on Align Technology in the 12 months to Nov 19, 2026: 0 purchases and 0 sales, by 0 members. In the 12 months before that: 5 disclosures.
Funds and stakes
Fund 13F filings recorded in the 12 months show 23 new or larger positions and 28 smaller or closed positions. A 13F is a snapshot of holdings at the end of a quarter.
Capital World Investors now owns 5.3% of ALGN as a passive investor (filed Nov 13, 2026).
G. Zachary Gund, as trustee, sole manager or co-manager cut its ALGN stake below 5% (2.6%) (filed Aug 12, 2026).
Contracts, lobbying and filings
The Federal Register published a notice, "Certain Clear Aligners and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Granting In Part ", on Jun 8, 2026, naming the company.
The Federal Register published a notice, "Certain Clear Aligners and Components Thereof; Institution of Investigation", on Dec 29, 2025, naming the company.
FDA records list 2 device clearances for Align Technology between Nov 19, 2025 and Nov 19, 2026; the latest, on Sep 25, 2026: device clearance for Invisalign System (510(k) clearance, traditional: Substantially Equivalent).
FINRA short interest for ALGN on the settlement date of Oct 30, 2026 was 4,109,362 shares (-0.92% on the previous report), about 3.95 days of average volume.
Align Technology filed a Form 8-K on Oct 28, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors.
The company's own opening sentence of that report reads: "On October 26, 2026, the Board of Directors (the ' Board ') of Align Technology, Inc. (the ' Company ') appointed Jennifer L. Davis as Chief Executive Officer-elect and director of the Company, effective November 2, 2026 (the ' C..."
Its announcing sentence reads: "Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it..."
Press coverage listed by Finnhub: "Align Technology Sees iTero Revenue Rebound in 2027 After Pricing Cuts Outlook" (Yahoo, Nov 19, 2026).
Press coverage listed by Finnhub: "Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors" (Yahoo, Nov 18, 2026).
Press coverage listed by Finnhub: "Align Technology to Speak at Upcoming Financial Conference" (Yahoo, Nov 10, 2026).
ALGN closed at $155.17 on Nov 20, 2026, the last session on or before the end of the period.
From Oct 21, 2026 to Nov 20, 2026, the close moved from $151.37 to $155.17, a change of +2.5%.
Things to keep in mind
These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why.
A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade.
Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
An 8-K item says what the company reported, not what it means for the share price.
Headlines are listed as published by the outlets; OQRO has not checked them and does not summarise articles.
Share price moves are listed as context only; the filing does not explain them and other news can move a price.
This describes public filings. It is not investment advice.
In 13F filings for the quarter ended Sep 30, 2026, the largest positions that grew: Bridgewater Associates (increased, 26,757 shares); ARK Investment Management (increased, 203 shares); the largest that shrank: none on record. A 13F is a quarter-end snapshot with no trade date.
For fiscal 2025, the company's proxy statement reported total compensation of $19.2M for its principal executive officer, and an average of $4.32M for the other named executive officers.
Company reports, price and press
Align Technology filed a Form 8-K on Nov 18, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member.
The company's own opening sentence of that report reads: "On November 17, 2026, the Board of Directors (the 'Board') of Align Technology, Inc. (the 'Company') appointed Paul Clancy, 65, to the Board, effective immediately, and Ian Bell, 56, to the Board, effective December 10, 2026."
Align Technology filed a Form 8-K on Oct 28, 2026 (Items 5.02, 7.01) that OQRO classes as: changed a top executive or board member, and shared information with investors.
The company's own opening sentence of that report reads: "On October 26, 2026, the Board of Directors (the ' Board ') of Align Technology, Inc. (the ' Company ') appointed Jennifer L. Davis as Chief Executive Officer-elect and director of the Company, effective November 2, 2026 (the ' C..."
Align Technology filed a Form 8-K on Aug 31, 2026 (Item 5.02) that OQRO classes as: changed a top executive or board member.
The company's own opening sentence of that report reads: "On August 27, 2026, the Board of Directors (the 'Board') of Align Technology, Inc. (the 'Company') appointed Quentin Blackford, 48, to the Board. In connection with Mr. Blackford’s appointment, the Board increased the size of the..."
Press coverage listed by Finnhub: "Align Technology Sees iTero Revenue Rebound in 2027 After Pricing Cuts Outlook" (Yahoo, Nov 19, 2026).
Press coverage listed by Finnhub: "Paul J. Clancy and Ian Bell to Join Align Technology Board of Directors" (Yahoo, Nov 18, 2026).
Press coverage listed by Finnhub: "Align Technology to Speak at Upcoming Financial Conference" (Yahoo, Nov 10, 2026).
ALGN closed at $163.96 on Nov 18, 2026, the last session on or before the end of the period.
From Oct 19, 2026 to Nov 18, 2026, the close moved from $149.00 to $163.96, a change of +10.0%.
Who holds it
670 funds reported a stake in Align Technology in their 13F for Q2 2026. The largest by value: BlackRock, Inc. (6.1% of the value reported), VANGUARD CAPITAL MANAGEMENT LLC (6.0% of the value reported), FMR LLC (5.6% of the value reported).
Attention
The English Wikipedia article on Align Technology was read about 74 times a day in the 7 days to Nov 18, 2026, against a usual 83 a day over the 90 days before. Reads measure attention, not buying or selling.
Things to keep in mind
These are counts of the filings OQRO holds, in the days they were filed; a busy or quiet month does not say why.
A Form 4 reports a transaction; it does not say why it was made, and some follow trading windows or pre-arranged plans. Congress reports give only amount ranges and arrive after the trade.
Total compensation in a proxy statement counts stock and option awards at their grant-date value, not what was sold.
An 8-K item says what the company reported, not what it means for the share price.
Headlines are listed as published by the outlets; OQRO has not checked them and does not summarise articles.
Share price moves are listed as context only; the filing does not explain them and other news can move a price.
This describes public filings. It is not investment advice.
People read Align Technology's Wikipedia article about 75 times a day over the last week, close to the 82 on a usual day of the three months before.
May 16, 2026Busiest day: 480 views on May 20, 2026Nov 21, 2026
Views of the article Align Technology, by people (Wikimedia leaves out known bots). More readers means more attention, from news, results or anything else; it does not say anyone bought or sold. Source: Wikimedia pageviews.
FDA, last 12 months
2 approvals or clearances and 0 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
33 certified in FY2026 Q3, vs 40 a year earlier. 33 positions in total, median offered wage $159K a year.
Expert Software Engineer · 3Sr. Software Engineer · 23D C Software Engineer · 1Analyst I · 1Anayst II · 1
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Where the revenue comes from
Latest quarter
The three months Jul 1, 2026 to Sep 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Nov 4, 2026. Quarterly reports are not audited. Read the filing
By business segment
Clear Aligner$839M83%
+4.2% on the same quarter a year earlier ($806M). Operating income $310M, a 37% margin
Systems and Services$175M17%
−7.6% on the same quarter a year earlier ($190M). Operating income $67M, a 38% margin
Total revenue$1.01B+1.9%
By region
Other International$410M40%
+9.5% on the same quarter a year earlier ($374M)
U.S.$384M38%
−6.4% on the same quarter a year earlier ($411M)
Switzerland$220M22%
+4.6% on the same quarter a year earlier ($211M)
Total revenue$1.01B+1.9%
The full fiscal year ended Dec 31, 2025
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 27, 2026. Read the filing
By business segment
Clear Aligner$3.25B80%
+0.5% on the year before ($3.23B). Operating income $1.03B, a 32% margin
Systems and Services$790M20%
+2.7% on the year before ($769M). Operating income $306M, a 39% margin
Total revenue$4.03B+0.9%
By region
U.S.$1.66B41%
−2.0% on the year before ($1.7B)
Other International$1.45B36%
+10% on the year before ($1.32B)
Switzerland$921M23%
−6.4% on the year before ($984M)
Total revenue$4.03B+0.9%
The year in the managers' words
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 9,000 words.
From “Our Strategic Growth Drivers”, in the company's words
We strive to help our doctor customers move their practices forward by connecting them with new patients, providing digital solutions to help increase practice efficiency and helping them deliver the best possible treatment outcomes and experiences to millions of people around the world. We strive to achieve this through our continued focus on, and execution of, our strategic growth drivers: International Expansion: Continually increasing the presence of our operations and commercial organization globally, expanding our products and service offerings and training and educating more doctors in more markets. General Practitioner dentists (“GP”) treatment: Making teeth straightening more relevant for GPs by enabling them to effectively scan, identify, treat, and monitor malocclusion.
What the section covers (39 headings)
Executive Overview of Results
Our Strategic Growth Drivers
Trends and Uncertainties
Macroeconomic Challenges, Trade Impediments and Geopolitical Tensions
2025 Restructuring
Changing Product Preferences
Key Financial and Operating Metrics
Other Statistical Data and Trends
Results of Operations
Net Revenues by Reportable Segment
Clear Aligner Case Volume
Clear Aligner
Systems and Services
Cost of net revenues and gross profit (in millions)
And 25 more headings in the filing.
Source: SEC EDGAR, Form 10-K filed Feb 27, 2026 and Form 10-Q filed Nov 4, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
Risk factors in the annual report
Latest annual report filed Feb 27, 2026, compared with the one filed Feb 28, 2025. Read the filing
New risk factors in the latest annual report (3 headings)
We are subject to foreign currency exchange fluctuations, which could have a material adverse effect on our financial condition or results of operations.
Our results of operations may be adversely affected if doctors at DSOs, orthodontic service organizations (“OSOs”) or other large group practices reduce, delay, or do not increase their purchasing of our products and services in ways that reduce adoption of our products and services.
We are subject to various laws relating to privacy, data protection, data governance and cybersecurity, and face risks related to the data we collect, process, and share.
Legal proceedings (Item 3)
The information set forth in Note 8 “Legal Proceedings” of the Notes to Consolidated Financial Statements in Part II, Item 8 of this Form 10-K is incorporated herein by reference.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 27, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Short sale volume: 66.7% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 59.2%. FINRA daily files, to Nov 20, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
Off-exchange trading: 46.1% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (34.0% on ATS, 12.1% with other brokers), close to its 26-week average of 46.0%. Weeks of Oct 5 to Oct 30, 2026.
Week of May 4ATSOther off-exchangeFull height = all shares tradedWeek of Oct 26
Largest ATS: UBS ATS (13.0%), INTELLIGENT CROSS LLC (12.3%), SIGMA X2 (11.6%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.